New research facility at the forefront of genomic engineering revolution
31 March 2016
Queensland life sciences and biomedical researchers can now access the rapid, precise and low-cost gene editing technology that is revolutionising biological research, agriculture, medicine and biotechnology.
IMB recently launched its new Queensland Facility for Advanced Genome Editing (QFAGE), based at The University of Queensland’s St Lucia campus, which provides expert genetic modification services using CRISPR/Cas9 genome editing technology in mice.
The facility offers a flexible service to assist life sciences and biomedical research groups in reaching their functional genomics goals.
Services are overseen by IMB Group Leader Professor Peter Koopman, whose lab has successfully produced dozens of TG and CRISPR/Cas9 models, and the facility is managed by Dr Johnny Huang, who has several years of experience managing a commercial mouse TG and knockout mouse facility.
The team’s combined experience assures a quality service that maximises experimental success.
Visit the website to find out more or book an appointment to discuss your project.
What is CRISPR-Cas9 and how does it work? How do we edit genes?
University of California, Berkeley geneticist and CRISPR/Cas9 co-inventor Jennifer Doudna explains.
Source: UC Berkeley YouTube channel